Social Media Use Reduction for Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if reducing social media use affects e-cigarette consumption among young adults. Researchers seek to understand whether less time on social media influences vaping habits, mental health, and the type of content viewed online. Participants will complete surveys and share screenshots of their social media activity. Ideal candidates are young adults aged 18-25 who live in the U.S., vape occasionally, use social media daily, and own a smartphone. Participants will be divided into two groups: one will reduce social media use (Social Media Use Reduction), while the other will continue as usual. This unphased trial offers a unique opportunity to contribute to understanding the impact of social media on vaping and mental health.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on social media use and vaping, so it's unlikely that your medications will be affected.
What prior data suggests that this social media use reduction is safe for young adults?
Research has shown that reducing social media use might assist young people who want to stop vaping. Although specific safety data for reducing social media use is not available, this change is generally considered safe. Since this trial does not involve medication or physical treatment, no known side effects exist from simply using social media less. The main goal is to determine if this change can help lower e-cigarette use and improve mental health.12345
Why are researchers excited about this trial?
Researchers are excited about the social media use reduction approach for vaping cessation because it tackles the problem from a behavioral angle rather than relying on medications like nicotine replacement therapies or prescription drugs. Most traditional treatments for vaping focus on reducing cravings with substances such as nicotine patches or gums. This new method is different because it aims to reduce vaping by cutting down on social media usage, which is thought to influence vaping behaviors in young people. By addressing the digital habits that might encourage vaping, this approach could offer a novel and non-pharmacological way to help individuals quit.
What evidence suggests that reducing social media use is effective for reducing e-cigarette use?
This trial will compare Social Media Use Reduction with Social Media Use as Usual. Research has shown that reducing social media use might help young adults vape less. Studies have found that digital tools, such as personalized messages on social media, can aid in quitting vaping. For instance, a program that sent text messages led to more teens reporting they quit vaping. Another study discovered that online support increased confidence in quitting. Overall, these methods seem promising for helping young people reduce their e-cigarette use.13467
Who Is on the Research Team?
Erin A Vogel, PhD
Principal Investigator
University of Oklahoma
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-25 in the U.S. who vape on some days and use social media daily with a smartphone. It's not specified who can't join, but typically those with conditions affecting results or unable to follow the protocol might be excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Measurement
Participants report time spent on social media, vaping-related content exposure, social comparison, mental health, and vaping behavior
Experimental
Participants are randomized to reduce social media use or continue as usual for a 3-month period
Follow-up
Participants are monitored for changes in vaping behavior and mental health after the experimental period
What Are the Treatments Tested in This Trial?
Interventions
- Social Media Use Reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
University of Wisconsin, Madison
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
University of Southern California
Collaborator
Stanford University
Collaborator